For the improvement of the medical device sector government is taking efforts and updating guidelines time to time. It is hard for the manufacturer /service provider to maintain all the records of the new updates and work as per the new regulations . To address this situation we provide regulatory services and help our clients to move ahead with their projects . Recently Government of India issued new guideline about standard operating procedure (SoPs) for testing medical devices, which will strengthen the infrastructure for the approval of medical devices. Currently with no mandatory regulation on drugs and pharmaceutical line for taking samples and conducting audit, all states have developed laboratories as per their requirement and ability. In India we have different categories of medical devices and they may require different type of testing infrastructure. The meeting was held under the chairmanship of the secretary of the Department of Pharmaceuticals (Dop) to prepare the roadmap to improve testing infrastructure to enable a smoother transition to medical device licensing. For the submission of report two months timeframe is given to the committee.
- fo需要标准操作程序(sop)r the assurance that quality standards are mate by the manufacturer . we are helping manufacturer to develop their quality management system as per the requirement ofISO15378 certification. To complete the procedure for thiscontact usor you canwhatsapp usyour requirement .
Currently there is minimum mandatory requirement for state regulator on how many samples they can take and verify .once the medical device regulation come into force testing of medical devices will become mandatory, so the prime task for the working committee is to identify which facilities within the government and which independent ones are available in the country to test medical devices,” the official said.
“The committee will also tell us which category of product which lab may be able to test.We called on several stakeholders from the Central Drugs Standard Control Organization (CDSCO), industry, DoP, NIPER to do this exercise and give their report,” the official said.”
As per the latest update from CDSCO manufacturer of low risk devices (ClassA &ClassB) were required to undergo a mandatory registration regime until September 2022 and device manufacturers high-risk medical devices(Class C & D ) have been invited to do so until September 2023. After the mandatory registration period, these classes will respectively move to the licensing regime.
The goal is to prepare the industry for a easy transition regulatory regime. The tests had been commissioned by way of the CDSCO according with the standards; similarly, random samples also are in development. This workout will create an permitting surroundings and fill the existing gaps.
188金宝搏网站靠谱吗medical device consultancylaunched newsletter “Reguveda-Your guide for regulatory updates” to keep you updated with new regulations. Don’t forget to subscribe ourNewsletter.
References:
